Journal of Bronchology · 2002 · 62 citations · 16 references
MedicineOncologySurgeryOncologic SurgerySurgical OncologyThoracic OncologyAirway SurgeryEndoscopic Tumor ResectionLaser SurgeryLung CancerThoracic Oncology SurgeryThoracic SurgeryAblative Laser TherapyAirway Tumor SurgeryBronchial SurgeryBronchoplastic ResectionNd:yag Laser SurgeryNd:yag Laser TreatmentTracheobronchial TumorTumor Laser Ablation
From 1982 to 2000 we performed bronchoscopic Nd:YAG laser treatment on 245 benign tumors, 178 carcinoid tumors, and 38 carcinomas in situ (CISs). This experience has provided good insight into the indications for curative laser therapy without surgery. Our results indicate that, using proper resection technique, laser treatment is curative in most benign tumors, 25% of central typical carcinoids, and all accessible CISs. Potentially curable benign tumors are endoscopically accessible lesions with strictly endoluminal growth and a small implantation base. Typical carcinoids with the following features can be cured: small volume (<4–5 cm3), central strictly endoluminal location, pedunculated or limited implantation base (<1.5 cm2), and minor wall infiltration. All CISs accessible to Nd:YAG laser treatment are curable because these lesions are by definition confined to the bronchial epithelium, and the biologic effects of the beam penetrate to a depth of 3 to 5 mm. Because of the consistent absence of recurrence in all cases meeting these criteria, we contend that bronchoscopic Nd:YAG laser treatment is an alternative to surgery for CIS and selected typical carcinoids and benign tumors.
16
William D. Travis, Walter L. Rush, Douglas B. Flieder et al. · The American Journal of Surgical Pathology · 1998 · 806 citations
Endoscopic Treatment of Malignant Airway Obstructions in 2,008 Patients
Sergio Cavaliere, Federico Venuta, Pierfranco Foccoli et al. · CHEST Journal · 1996 · 399 citations
Brian C. McCaughan, Nael Martini, Manjit S. Bains · Journal of Thoracic and Cardiovascular Surgery · 1985 · 268 citations